Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the efficacy and safety of Prothione capsules for mild to moderate COVID-19 has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Drugs mentioned

• Prothione

Snippet

Sponsor: Prothione, LLC | Conditions: Coronavirus Disease 2019 (COVID-19) | Phase 2 | Status: COMPLETED